Mesa Laboratories, Inc. expected to post earnings of 3 cents a share - Earnings Preview
Mesa Laboratories, Inc. expected to post earnings of 3 cents a share - Earnings Preview
Mesa Laboratories, Inc. MLAB.OQ MLAB.O is expected to show a rise in quarterly revenue when it reports results on August 10 for the period ending June 30 2026
The Lakewood Colorado-based company is expected to report a 2.2% increase in revenue to $60.867 million from $59.54 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
LSEG's mean analyst estimate for Mesa Laboratories, Inc. is for earnings of 3 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts had fallen by about 10.5% in the last three months.
Wall Street's median 12-month price target for Mesa Laboratories, Inc. is $112.00, about 10.9% above its last closing price of $101.01
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2026 | 0.21 | 0.34 | -0.75 | Missed | -320.6 |
Dec. 31 2026 | 0.28 | 0.28 | 0.65 | Beat | 134.9 |
Sep. 30 2025 | 0.19 | 0.16 | 0.45 | Beat | 181.3 |
Jun. 30 2025 | 0.45 | 0.44 | 0.85 | Beat | 94.7 |
Mar. 31 2025 | 0.99 | 1.09 | -1.31 | Missed | -220.2 |
Dec. 31 2024 | 1.77 | 1.75 | -0.26 | Missed | -114.7 |
Sep. 30 2024 | 1.38 | 1.38 | 0.80 | Missed | -42.2 |
Jun. 30 2024 | 0.39 | 0.44 | 0.84 | Beat | 89.5 |
This summary was machine generated August 7 at 21:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Recent news on Mesa Laboratories
See all newsMesa Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Mesa Labs Q1 revenue rises as calibration, biopharma units grow
Mesa Laboratories, Inc. expected to post earnings of 3 cents a share - Earnings Preview
Mesa Laboratories Inc reports results for the quarter ended March 31 - Earnings Summary
Mesa Laboratories Q4 revenue rises on SDC growth